Do prescription drug advertisements educate the public? The consumer answers

Drug Information Journal

Volumn 39, Issue 1, 2005, Pages 25-33

  Young, Henry N ^c   Paterniti, Debora A ^a   Bell, Robert A ^b   Kravitz, Richard L ^b,c  

^a Depts of Int Med and Sociology

^b Department of Communication ^*

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug Advertising; Educational Value; Opinions

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; MONOAMINE OXIDASE INHIBITOR; SPASMOLYTIC AGENT;

ADULT; ADVERTIZING; AGED; ALLERGY; ARTICLE; ASTHMA; AWARENESS; CLINICAL ARTICLE; CLINICAL RESEARCH; CONSUMER; DEPRESSION; DIAGNOSTIC VALUE; DIRECT TO CONSUMER ADVERTIZING; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; EDUCATION; FEMALE; HEARTBURN; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC OPINION; QUALITY CONTROL; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT PLANNING;

EID: 13844251953     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150503900104     Document Type: Article

References (15)

1. Curran CF, Oh KE. Sources of drug information available to consumers. Drug Inf J. 2001;35:539-546.
2. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drug to consumers. N Engl J Med. 2002;346(7):498-505.
3. Bradley LR, Zito JM. Direct-to-consumer prescription drug advertising. Med Care. 1997;35:86-92.
4. Christensen TP, Ascione FJ, Bagozzi RP. Understanding how elderly patients process drug information: A test of a theory of information processing. Pharm Res. 1997;14:1589-1596.
5. Hollon MF, Larson EB, Koepsell TD, Downer AE. Direct-to-consumer marketing of osteoporosis drugs and bone densitometry. Ann Pharmacother. 2003;37(7-8):976-981.
6. Cohen EP. Direct-to-public advertisement of prescription drugs [Letter to the editor]. N Engl J Med. 1988;318:373-375.
7. Prescription drug advertising direct to the consumer. Pediatrics. 1991;88(1):174-175.
8. Griffith WA, Cangemi RR. Direct-to-consumer rx ads? Drug firms see plusses, minuses. Drug Topics. 1985;129:60-62.
9. Alperstein NM, Peyrot M. Consumer awareness of prescription drug advertising. J Advertising Res. 1993;33:50-56.
10. The Henry J. Kaiser Family Foundation. Understanding the effects of direct-to-consumer prescription drug advertising, November 2001. Available at: http://www.kff.org/rxdrugs/loader.cfm?url=/commonspot/security/getfile. cfm&PageID=13876. Accessed January 9, 2004.
11. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Int Med. 1999;14:651-657.
12. Cline RJW, Young HN. Marketing drugs, marketing health care relationships: A content analysis of visual cues in direct-to-consumer prescription drug advertising. Health Commun. 2004;16(2):131-57.
13. Hollon MF. Direct-to-consumer marketing of prescription drugs: Creating consumer demand. JAMA. 1999;281:382-384.
14. U.S. Department of Health and Human Services: Food and Drug Administration. Guidance for Industry - Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements. January 2004. Available at: http://www.fda.gov/cder/guidance/5669dft.pdf. Accessed July 6, 2004.
15. Doucette WR, Schommer JC. Consumer preferences for drug information after direct-to-consumer advertising. Drug Inf J. 1998;32:1081-1088.